Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Asahi Intecc in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $24.00.
Current Consensus is
The current consensus among 1 polled investment analysts is to hold stock in Asahi Intecc.
Asahi Intecc Co., Ltd. develops, manufactures, and sells medical devices in Japan and internationally. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. It also offers OEM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products, as well as ultra-fine stainless steel wire ropes, terminal processed products, etc. Asahi Intecc Co., Ltd. has business alliance agreement with Oncolys BioPharma. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was founded in 1976 and is headquartered in Aichi, Japan.